References
Habrawi Z, Melkus MW, Khan S, et al. Cryoablation: a promising non-operative therapy for low-risk breast cancer. Am J Surg. 2021;221(1):127–33.
Fine RE, Gilmore RC, Dietz JR, et al. Cryoablation without excision for low-risk early-stage breast cancer: 3-year interim analysis of ipsilateral breast tumor recurrence in the ICE3 trial. Ann Surg Oncol. 2021;28(10):5525–34.
Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 2009;58(1):1–11.
Denkert C, von Minckwitz G, Darb-Esfahani S, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19(1):40–50.
Khan SY, Melkus MW, Rasha F, et al. Tumor infiltrating lymphocytes (TILs) as a biomarker of abscopal effect of cryoablation in breast cancer—a pilot study. Ann Surg Oncol. https://doi.org/10.1245/s10434-021-11240-2.
Acknowledgment
The research reported in the source article was funded through an endowment for Breast Center of Excellence funded by ASCO Equipment.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Sonia Y. Khan, Michael W. Melkus, and Rakhshanda Layeequr Rahman have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Khan, S.Y., Melkus, M.W. & Layeequr Rahman, R. ASO Author Reflections: How can we Measure an Abscopal Effect Seen with Cryoablation?. Ann Surg Oncol 29, 2926–2927 (2022). https://doi.org/10.1245/s10434-021-11220-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-11220-6